Harm Reduction Strategies Indian Medical PG Practice Questions and MCQs
Practice Indian Medical PG questions for Harm Reduction Strategies. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Harm Reduction Strategies Indian Medical PG Question 1: Which of the following opioids can be given intranasally?
- A. Tramadol
- B. Pethidine
- C. Buprenorphine
- D. Butorphanol (Correct Answer)
Harm Reduction Strategies Explanation: ***Butorphanol***
- **Butorphanol** is a synthetic opioid agonist-antagonist that is commonly available as an **intranasal spray** (Stadols NS) for the treatment of moderate to severe pain, especially for conditions like **migraines** [2].
- Its **high lipid solubility** and **good absorption across nasal mucosa** make it suitable for this route of administration, providing rapid onset of action.
- This is the **most well-established and widely used intranasal opioid formulation** in clinical practice.
*Tramadol*
- **Tramadol** is an opioid analgesic with a primary route of administration that is **oral** or **intravenous**.
- It is not typically formulated or administered via the **intranasal route** due to lower bioavailability and potential for local irritation.
*Pethidine*
- **Pethidine** (meperidine) is an opioid typically given via **intramuscular**, **subcutaneous**, or **intravenous** injection [1].
- It is not formulated for **intranasal use**, and this route would not be an effective or safe delivery method for the drug due to poor absorption and potential for mucosal damage.
*Buprenorphine*
- **Buprenorphine** is a partial opioid agonist available in various formulations, including **sublingual**, **injectable**, and **transdermal** routes, particularly for opioid dependence treatment and pain management [3].
- While intranasal buprenorphine formulations exist, **sublingual remains the preferred and most commonly used route** in clinical practice due to excellent bioavailability and ease of administration [3].
- **Butorphanol** is the classic intranasal opioid emphasized in medical education.
Harm Reduction Strategies Indian Medical PG Question 2: A 55-year-old drug addict from California presents with euphoria, altered time perception, and conjunctival injection, along with impairment of judgment. The most likely cause of this is addiction to which substance?
- A. Marijuana (Correct Answer)
- B. Cocaine
- C. Phencyclidine
- D. Benzodiazepine
Harm Reduction Strategies Explanation: ***Marijuana***
- **Euphoria**, altered time perception, and **conjunctival injection** are classic symptoms associated with marijuana use.
- Impairment of judgment and coordination are also common effects of **cannabis intoxication**.
*Cocaine*
- Cocaine intoxication typically presents with **psychomotor agitation**, **tachycardia**, **hypertension**, and **dilated pupils**, not conjunctival injection.
- While it causes euphoria and altered perception, the specific combination of symptoms points away from cocaine.
*Phencyclidine*
- **Phencyclidine (PCP)** often causes **nystagmus**, violence, and **dissociative symptoms** like derealization and depersonalization, which are not described.
- It can also lead to severe agitation and unpredictable behavior, distinct from the patient's presentation.
*Benzodiazepine*
- Benzodiazepine intoxication or abuse typically leads to **sedation**, ataxia, and **respiratory depression**, rather than euphoria and conjunctival injection.
- The effects are more consistent with central nervous system depression.
Harm Reduction Strategies Indian Medical PG Question 3: Which intervention has shown the highest return on investment in national STI control programs?
- A. Mobile testing units
- B. Online partner notification
- C. Integration with HIV services (Correct Answer)
- D. Mass media campaigns
Harm Reduction Strategies Explanation: ***Integration with HIV services***
- This approach offers the **highest return on investment** for national STI control programs as it leverages existing infrastructure and funding for HIV services, maximizing resource utilization.
- **Syndromic management of STIs integrated with HIV care** allows for efficient screening, diagnosis, and treatment of both conditions simultaneously, reaching high-risk populations effectively.
- **India's National AIDS Control Programme (NACP)** successfully demonstrates this model, with STI/RTI services integrated into HIV testing and counseling centers, reducing duplication and operational costs.
- **WHO guidelines strongly recommend** this integration strategy as the most cost-effective approach for national STI control programs, particularly in resource-limited settings.
*Mobile testing units*
- While helpful for reaching underserved populations, **mobile units have high operational costs** including staffing, vehicle maintenance, and equipment, which significantly limit their overall return on investment.
- Their effectiveness is often localized and may not provide broad, sustainable impact across an entire national program compared to integrated services.
*Online partner notification*
- This method's reach is limited by **digital literacy and access barriers**, potentially excluding high-risk groups without internet access, particularly relevant in the Indian context.
- While it can improve partner tracing in certain populations, the initial setup costs and limited universal applicability reduce its overall cost-effectiveness compared to integrated clinical services.
*Mass media campaigns*
- These campaigns require **significant financial investment** for broadcast time and creative development, with outcomes that are difficult to quantify in terms of direct STI reduction.
- While effective for raising general awareness, they generate less measurable return on investment for direct STI control services compared to targeted clinical interventions like integrated service delivery.
Harm Reduction Strategies Indian Medical PG Question 4: Which of the following is a pure opioid antagonist?
- A. Naloxone (Correct Answer)
- B. Buprenorphine
- C. Pentazocine
- D. Morphine
Harm Reduction Strategies Explanation: ***Naloxone*** - **Naloxone** is a pure opioid antagonist that rapidly reverses the effects of opioid agonists by competing for opioid receptor binding sites [1,2]. - It has a high affinity for μ-opioid receptors and acts as a competitive antagonist [1], making it clinically useful for treating **opioid overdose**. *Buprenorphine* - **Buprenorphine** is a **partial opioid agonist** at the μ-opioid receptor and an antagonist at the κ-opioid receptor [4]. - It can precipitate withdrawal in opioid-dependent individuals if administered while full agonists are present due to its partial agonistic activity. *Pentazocine* - **Pentazocine** is a **mixed opioid agonist-antagonist**, acting as a partial agonist or antagonist at μ-opioid receptors and an agonist at κ-opioid receptors. - Its effects can vary, including analgesia (kappa agonism) and potential for withdrawal symptoms in opioid-dependent individuals (mu antagonism). *Morphine* - **Morphine** is a potent **full opioid agonist** that primarily acts on μ-opioid receptors, producing analgesia, sedation, and euphoria [3]. - It does not block opioid receptors; instead, it activates them, leading to its therapeutic and adverse effects.
Harm Reduction Strategies Indian Medical PG Question 5: Which drug is used for long-term maintenance in opioid addiction?
- A. Naloxone
- B. Nalorphine
- C. Methadone (Correct Answer)
- D. Butorphanol
Harm Reduction Strategies Explanation: ***Methadone***
- **Methadone** is a long-acting opioid agonist used daily for **maintenance therapy** in opioid addiction, preventing withdrawal symptoms and reducing cravings.
- Its long half-life allows for once-daily dosing, which helps in stabilizing patients and reducing illicit opioid use.
- Along with **buprenorphine** (a partial agonist), methadone is one of the two primary medications used for opioid maintenance therapy.
*Naloxone*
- **Naloxone** is an **opioid antagonist** used to rapidly reverse opioid overdose by competitively binding to opioid receptors.
- It is not used for long-term maintenance but rather as an emergency intervention to counteract life-threatening respiratory depression.
*Nalorphine*
- **Nalorphine** is an older, mixed opioid agonist-antagonist that was once used for opioid overdose but has largely been replaced by naloxone due to its own opioid agonistic effects.
- It does not have a role in current long-term maintenance treatment for opioid addiction.
*Butorphanol*
- **Butorphanol** is a mixed opioid agonist-antagonist primarily used as an analgesic, particularly for pain management.
- It can precipitate withdrawal in opioid-dependent individuals and is not indicated for the treatment or maintenance of opioid addiction.
Harm Reduction Strategies Indian Medical PG Question 6: The most widely used substance causing dependence worldwide is:
- A. Cocaine
- B. Cannabis
- C. Amphetamines
- D. Alcohol (Correct Answer)
Harm Reduction Strategies Explanation: ***Alcohol***
- **Alcohol** is the most widely consumed psychoactive substance globally, leading to a significant burden of dependence and related health issues.
- Its widespread availability, social acceptance, and addictive properties contribute to its high rates of dependence across diverse populations.
*Cocaine*
- While **cocaine** is a powerful and highly addictive stimulant, its use and dependence are not as prevalent globally as alcohol.
- The geographical distribution and historical context of cocaine use are more concentrated compared to the ubiquitous nature of alcohol consumption.
*Cannabis*
- **Cannabis** is one of the most commonly used illicit drugs worldwide, and it can cause dependence, but its overall prevalence of dependence is lower than that of alcohol.
- The perception of lower harm and increased legalization in some regions have led to higher rates of use, but alcohol still surpasses it in terms of global dependence rates.
*Amphetamines*
- **Amphetamines**, including methamphetamine, are potent stimulants known for their high potential for dependence.
- However, their global usage and rates of dependence, while significant in certain regions, do not reach the broad societal impact and prevalence seen with alcohol.
Harm Reduction Strategies Indian Medical PG Question 7: In the context of AIDS control programs, which sexually transmitted infection is specifically treated with the blue-colored pack?
- A. Urethral discharge
- B. Scrotal swelling
- C. Genital ulcers (Correct Answer)
- D. Ano-rectal discharge
Harm Reduction Strategies Explanation: ***Genital ulcers***
- The "blue-colored pack" in AIDS control programs is specifically designed for the syndromic management of **genital ulcer disease (GUD)**.
- Treating GUD is crucial for AIDS control strategies because genital ulcers facilitate **HIV transmission** by breaking the mucosal barrier.
*Urethral discharge*
- Urethral discharge is typically managed with the **green-colored pack**, which targets pathogens commonly causing urethritis.
- This symptom primarily indicates **gonorrhea** or **chlamydia**, which are distinct from genital ulcers in their syndromic management.
*Scrotal swelling*
- Scrotal swelling is managed with the **white-colored pack**, which focuses on conditions like **epididymitis** or **orchitis**.
- This syndromic approach addresses infections causing inflammation of the testes and epididymis, which are different from GUD.
*Ano-rectal discharge*
- Ano-rectal discharge is generally addressed with the **green-colored pack**, similar to urethral discharge, targeting pathogens like **gonorrhea** and **chlamydia**.
- While anogenital infections can manifest in various ways, discharge from the anorectal area is managed differently from genital ulcers.
Harm Reduction Strategies Indian Medical PG Question 8: A 50-year-old male with a history of chronic alcoholism presents with altered sensorium and signs of portal hypertension. What is the most appropriate initial management step?
- A. Perform upper gastrointestinal endoscopy (UGIE)
- B. Administer chlordiazepoxide
- C. Administer thiamine
- D. Administer lactulose (Correct Answer)
Harm Reduction Strategies Explanation: ***Administer lactulose***
- The patient's presentation with altered sensorium and chronic alcoholism, coupled with signs of portal hypertension, strongly suggests **hepatic encephalopathy**. [1]
- **Lactulose** is the most appropriate initial management step because it helps to reduce ammonia absorption from the gut by acidifying the colon and acting as an osmotic laxative, thereby improving neurological function. [1]
*Perform upper gastrointestinal endoscopy (UGIE)*
- While **portal hypertension** can lead to varices and bleeding, an UGIE is an invasive procedure and not the immediate priority for a patient presenting with altered sensorium due to suspected hepatic encephalopathy.
- UGIE would be indicated if there were active **gastrointestinal bleeding** (e.g., hematemesis, melena) or hemodynamic instability, which are not explicitly mentioned as the primary concern.
*Administer chlordiazepoxide*
- **Chlordiazepoxide** is a benzodiazepine used to treat **alcohol withdrawal syndrome** (delirium tremens), which can also cause altered mental status.
- However, given the signs of portal hypertension, **hepatic encephalopathy** is a more likely cause of altered sensorium, and benzodiazepines can worsen it by precipifying sedation.
*Administer thiamine*
- **Thiamine** administration is crucial in chronic alcoholics to prevent and treat **Wernicke-Korsakoff syndrome**, which can cause altered mental status, ophthalmoplegia, and ataxia. [2]
- While important in all chronic alcoholics, addressing the potentially life-threatening ammonia toxicity in **hepatic encephalopathy** with lactulose takes precedence in the immediate management of altered sensorium.
Harm Reduction Strategies Indian Medical PG Question 9: Which of the following pain medications requires the MOST caution in a patient with a history of opioid addiction?
- A. Morphine (Correct Answer)
- B. Oxycodone
- C. Methadone
- D. Buprenorphine
Harm Reduction Strategies Explanation: ***Morphine***
- Morphine is a **full mu-opioid agonist** with the highest potential for **abuse, dependence, and relapse** in patients with a history of opioid addiction due to its strong **euphoric effects**.
- It carries the greatest risk of triggering **addictive behaviors** and relapse in recovering patients, making it require the MOST caution in this population.
- Use should be avoided if possible, or limited to short-term use under strict supervision with alternative analgesics preferred.
*Oxycodone*
- Oxycodone is another **potent full opioid agonist** with very high abuse potential, nearly equivalent to morphine.
- While requiring extreme caution, morphine remains the prototypical high-risk opioid in addiction-prone patients.
*Methadone*
- Methadone is a **long-acting full opioid agonist** used in opioid maintenance therapy with significant abuse potential.
- However, when used appropriately in supervised programs, it has a role in addiction treatment, though acute pain prescribing requires caution due to its **long half-life and QTc prolongation risk**.
*Buprenorphine*
- Buprenorphine is a **partial mu-opioid agonist** with a **ceiling effect** that limits respiratory depression and euphoria.
- It is the **standard medication for opioid use disorder treatment** and has LOWER abuse potential than full agonists.
- While it requires careful timing to avoid precipitated withdrawal in opioid-dependent patients, it is actually SAFER than full agonists in patients with addiction history due to reduced relapse risk.
Harm Reduction Strategies Indian Medical PG Question 10: What are nitrergic neurons?
- A. Postganglionic neurons releasing nitric oxide.
- B. First-order neurons releasing nitric oxide. (Correct Answer)
- C. Postganglionic neurons releasing substance P.
- D. First-order neurons releasing calcitonin gene-related peptide.
Harm Reduction Strategies Explanation: **Nitrergic neurons** are a specific class of neurons that utilize **Nitric Oxide (NO)** as their primary neurotransmitter. Unlike classical neurotransmitters stored in vesicles, NO is a gaseous molecule synthesized on demand by the enzyme **Neuronal Nitric Oxide Synthase (nNOS)** [1].
**Why Option B is Correct:**
In the context of the autonomic and enteric nervous systems, nitrergic neurons are typically **first-order neurons** (primary neurons) that release NO to mediate physiological functions. In the gastrointestinal tract, they are the principal inhibitory neurons of the myenteric plexus, responsible for the relaxation of smooth muscles (e.g., the Lower Esophageal Sphincter and the Sphincter of Oddi) [2].
**Analysis of Incorrect Options:**
* **Option A:** While some postganglionic parasympathetic fibers (like those in the corpora cavernosa) release NO, the term "nitrergic neuron" fundamentally refers to the primary/first-order signaling unit in the inhibitory pathways of the enteric nervous system.
* **Option C & D:** Substance P and Calcitonin Gene-Related Peptide (CGRP) are neuropeptides associated with **peptidergic neurons**, primarily involved in pain transmission (nociception) and vasodilation, not nitrergic signaling [2].
**High-Yield Clinical Pearls for NEET-PG:**
* **Achalasia Cardia:** This condition results from the selective **loss of nitrergic neurons** in the myenteric (Auerbach's) plexus, leading to the failure of the Lower Esophageal Sphincter (LES) to relax.
* **Erectile Dysfunction:** NO released from nitrergic nerves in the penis activates guanylyl cyclase, increasing cGMP and causing vasodilation [1]. Sildenafil works by preventing the breakdown of this cGMP.
* **Infantile Hypertrophic Pyloric Stenosis:** Also associated with a deficiency of nNOS and nitrergic innervation at the pylorus.
More Harm Reduction Strategies Indian Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
)